Drugs / GVAX Pancreas
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01417000 | Sep 2011 → Oct 2016 | malignant pancreatic neoplasm | Aduro Biotech, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GVAX Pancreas | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01417000 ↗ |
| Modality | Vaccine | “GVAX pancreas vaccine” NCT01417000 ↗ |
| Route | Other | “GVAX pancreas vaccine (GVAX, 5 × 10e8 cells) administered by intradermal injection” NCT01417000 ↗ |